Trial
NCT06247345
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alzheimer's Disease Expert Lab (ADEL), Inc.
Collaborators
Oscotec Inc.
Condition
Alzheimer Disease
Intervention
ADEL-Y01 - healty participants
Why stopped
Study discontinued due to sponsor transition and strategic decision not to continue the protocol.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-30